CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway

Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2...

Full description

Saved in:
Bibliographic Details
Published inCell death & disease Vol. 13; no. 9; pp. 796 - 14
Main Authors Yang, Peng, Zhang, Dongsheng, Wang, Tuo, Ji, Jiangzhou, Jin, Chi, Peng, Chaofan, Tan, Yuqian, Zhou, Jiahui, Wang, Lu, Feng, Yifei, Sun, Yueming
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 19.09.2022
Springer Nature B.V
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN2041-4889
2041-4889
DOI10.1038/s41419-022-05240-7

Cover

Abstract Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVs WEE2-AS1 leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVs WEE2-AS1 interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis.
AbstractList Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVs WEE2-AS1 leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVs WEE2-AS1 interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis.
Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVsWEE2-AS1 leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVsWEE2-AS1 interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis.
Abstract Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVsWEE2-AS1 leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVsWEE2-AS1 interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis.
Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVsWEE2-AS1 leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVsWEE2-AS1 interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis.Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVsWEE2-AS1 leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVsWEE2-AS1 interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis.
Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression. However, the precise biological functions and molecular mechanisms of CAFs in the TME have yet to be understood. Here, we demonstrate that WEE2-AS1 is highly expressed in the CAF-derived small extracellular vesicles (sEVs). Moreover, WEE2-AS1 is markedly higher in plasma sEVs of CRC patients than in healthy subjects and its high level predicts advanced pathological staging and poor survival. Then, we conducted a series of in vitro and in vivo experiments. Elevated expression of WEE2-AS1 in sEVs increases CRC cell proliferation in vitro. Importantly, aberrant CAF-sEVs leads to tumor formation and progression in BALB/c nude mice and promotes AOM/DSS-induced tumorigenesis. Mechanistically, WEE2-AS1 functions as a modular scaffold for the MOB1A and E3 ubiquitin-protein ligase praja2 complexes, leading to MOB1A degradation via the ubiquitin-proteasome pathway. The Hippo pathway is then inhibited and more YAP are transported into the nucleus, where they activate downstream gene transcription. Together, our data reveal that CAF-sEVs interacts with MOB1A, promotes degradation of MOB1A, inhibits the Hippo pathway, and facilitates the growth of CRC cells. Hence, exosomal WEE2-AS1 may be a promising therapeutic target and circulating biomarker for CRC diagnosis and prognosis.
ArticleNumber 796
Author Tan, Yuqian
Zhou, Jiahui
Yang, Peng
Jin, Chi
Wang, Tuo
Wang, Lu
Sun, Yueming
Zhang, Dongsheng
Peng, Chaofan
Feng, Yifei
Ji, Jiangzhou
Author_xml – sequence: 1
  givenname: Peng
  surname: Yang
  fullname: Yang, Peng
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
– sequence: 2
  givenname: Dongsheng
  surname: Zhang
  fullname: Zhang, Dongsheng
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
– sequence: 3
  givenname: Tuo
  surname: Wang
  fullname: Wang, Tuo
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
– sequence: 4
  givenname: Jiangzhou
  surname: Ji
  fullname: Ji, Jiangzhou
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
– sequence: 5
  givenname: Chi
  surname: Jin
  fullname: Jin, Chi
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
– sequence: 6
  givenname: Chaofan
  surname: Peng
  fullname: Peng, Chaofan
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
– sequence: 7
  givenname: Yuqian
  surname: Tan
  fullname: Tan, Yuqian
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
– sequence: 8
  givenname: Jiahui
  surname: Zhou
  fullname: Zhou, Jiahui
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
– sequence: 9
  givenname: Lu
  surname: Wang
  fullname: Wang, Lu
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
– sequence: 10
  givenname: Yifei
  surname: Feng
  fullname: Feng, Yifei
  email: fengyifei1982@163.com
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
– sequence: 11
  givenname: Yueming
  orcidid: 0000-0002-0543-134X
  surname: Sun
  fullname: Sun, Yueming
  email: sunyueming@njmu.edu.cn
  organization: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, The First School of Clinical Medicine, Nanjing Medical University, The Colorectal Institute of Nanjing Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36123327$$D View this record in MEDLINE/PubMed
BookMark eNqNUstu1DAUjVARLaU_wAJZYsMm4FdeG6RhNKWViroAxNK6cW4yHmXsYHumzBfw2ySdobRdVHjjxz3n6Pie-zI5ss5ikrxm9D2jovwQJJOsSinnKc24pGnxLDnhVLJUlmV1dO98nJyFsKLjEoLyLH-RHIuccSF4cZL8ns_O0wa92WJD8JcLbg09-bFY8HT2lZEWtOlNhIiBaNc7jzqOdQ1WoyeDd53HEIyzZGtguq9dNLYjDXYeGohTxbXky_UnNiPREWOXpjaRxCWSCzMMjgwQlzewe5U8b6EPeHbYT5Pv54tv84v06vrz5Xx2lepM0pjKos3ykmmmacm4LjGDApiuWS5AYImyqQWTGbI8R57XFEXethRa3tQcQaM4TS73uo2DlRq8WYPfKQdG3T443ynw0egeFc2yQreiQawyKShCU8icMiplBW1bFqOW2Gtt7AC7G-j7O0FG1ZSS2qekxpTUbUpqYn3cs4ZNvcZGo40e-gdWHlasWarObVUly4yxahR4dxDw7ucGQ1RrEzT2PVh0m6B4wXJaFgVnI_TtI-jKbbwdGzyhspwzWU2O3tx3dGfl75SMgHIP0N6F4LFVepqJMdzRoOmf_i1_RP2vFh0aG0aw7dD_s_0E6w_fEPIJ
CitedBy_id crossref_primary_10_1007_s00432_023_05273_1
crossref_primary_10_3390_nu15214512
crossref_primary_10_3390_biomedicines11061761
crossref_primary_10_1016_j_bbrc_2022_12_026
crossref_primary_10_3389_fimmu_2023_1161628
crossref_primary_10_3390_ncrna10060054
crossref_primary_10_1016_j_bbagen_2025_130796
crossref_primary_10_3389_fimmu_2024_1469918
crossref_primary_10_1016_j_canlet_2024_217244
crossref_primary_10_1016_j_plabm_2025_e00464
crossref_primary_10_1038_s41420_024_02235_5
crossref_primary_10_3390_ijms252312548
crossref_primary_10_1016_j_cca_2024_117849
crossref_primary_10_1186_s12943_023_01860_5
crossref_primary_10_1038_s41420_023_01760_z
crossref_primary_10_2147_JIR_S460730
crossref_primary_10_1016_j_intimp_2024_113666
crossref_primary_10_1080_19768354_2023_2281370
crossref_primary_10_3390_biomedicines11092411
crossref_primary_10_20517_evcna_2024_16
crossref_primary_10_3390_cancers15041107
crossref_primary_10_3389_fonc_2024_1374742
crossref_primary_10_7717_peerj_16159
crossref_primary_10_1016_j_trsl_2024_04_003
crossref_primary_10_31083_j_fbl2811302
crossref_primary_10_3389_fonc_2022_1014949
crossref_primary_10_1039_D3NR05656B
crossref_primary_10_3390_cells13141195
crossref_primary_10_1016_j_bbamcr_2024_119827
crossref_primary_10_1038_s41467_024_46531_1
crossref_primary_10_3390_cancers15030959
crossref_primary_10_1007_s00239_023_10150_z
Cites_doi 10.1152/physrev.00048.2019
10.1038/s41467-021-22638-7
10.1038/nrgastro.2016.59
10.1053/j.gastro.2019.11.029
10.1038/ncomms2791
10.1186/s12943-019-1043-x
10.1158/0008-5472.CAN-18-3962
10.1080/20013078.2019.1703244
10.1016/j.cell.2009.02.006
10.3892/mmr.2020.11625
10.1038/s41467-018-07810-w
10.1016/S0140-6736(19)32319-0
10.1158/1078-0432.CCR-17-2376
10.1186/s12943-018-0831-z
10.1016/j.bbrc.2020.01.170
10.1001/jamaoncol.2018.7229
10.1186/s12943-019-0957-7
10.1038/onc.2016.353
10.1186/s13059-018-1604-0
10.1038/nrc3458
10.1146/annurev-biochem-060815-014922
10.1101/gad.1602907
10.1038/s41571-020-00457-x
10.1038/s41573-018-0004-1
10.1038/s41575-019-0115-0
10.1016/j.bbrc.2018.11.091
10.1083/jcb.201211138
10.1158/2159-8290.CD-13-0202
10.1038/s41467-017-02583-0
10.1016/j.celrep.2019.11.035
10.1016/j.cub.2020.06.081
10.1186/s12943-019-1019-x
10.1146/annurev-biochem-013118-111829
10.1056/NEJMcibr1914890
10.1016/j.cmet.2019.06.001
10.1186/s12943-018-0863-4
10.1007/BF02705243
10.1002/ctm2.211
10.1126/science.aau6977
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
ADTOC
UNPAY
DOA
DOI 10.1038/s41419-022-05240-7
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Science Database (ProQuest)
Biological Science Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
Publicly Available Content Database



MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 6
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-4889
EndPage 14
ExternalDocumentID oai_doaj_org_article_0557cf3dee95430ead746010449aff87
10.1038/s41419-022-05240-7
PMC9485119
36123327
10_1038_s41419_022_05240_7
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
3V.
53G
5VS
70F
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
E3Z
EBLON
EBS
EMOBN
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
HZ~
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
O5R
O5S
O9-
OK1
PIMPY
PQQKQ
PROAC
RNT
RPM
SNYQT
TR2
UKHRP
W2D
AASML
AAYXX
CITATION
PHGZM
PHGZT
PQGLB
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ADRAZ
ADTOC
CAG
COF
EJD
IPNFZ
RIG
UNPAY
ID FETCH-LOGICAL-c540t-47f5681c1c0812c8e5a7a1cb163a3e8e4db3145e166e26b0e36ff0af2db2eace3
IEDL.DBID M48
ISSN 2041-4889
IngestDate Fri Oct 03 12:52:38 EDT 2025
Sun Oct 26 03:39:59 EDT 2025
Tue Sep 30 17:19:11 EDT 2025
Fri Sep 05 13:16:04 EDT 2025
Tue Oct 07 06:49:26 EDT 2025
Thu Jan 02 22:52:31 EST 2025
Thu Apr 24 23:08:10 EDT 2025
Wed Oct 01 04:27:42 EDT 2025
Fri Feb 21 02:37:09 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License 2022. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
cc-by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-47f5681c1c0812c8e5a7a1cb163a3e8e4db3145e166e26b0e36ff0af2db2eace3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-0543-134X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41419-022-05240-7
PMID 36123327
PQID 2715621497
PQPubID 2041963
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_0557cf3dee95430ead746010449aff87
unpaywall_primary_10_1038_s41419_022_05240_7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9485119
proquest_miscellaneous_2716087721
proquest_journals_2715621497
pubmed_primary_36123327
crossref_citationtrail_10_1038_s41419_022_05240_7
crossref_primary_10_1038_s41419_022_05240_7
springer_journals_10_1038_s41419_022_05240_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-09-19
PublicationDateYYYYMMDD 2022-09-19
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-19
  day: 19
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cell death & disease
PublicationTitleAbbrev Cell Death Dis
PublicationTitleAlternate Cell Death Dis
PublicationYear 2022
Publisher Nature Publishing Group UK
Springer Nature B.V
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: Nature Publishing Group
References Dekker, Tanis, Vleugels, Kasi, Wallace (CR2) 2019; 394
Anderson, Simon (CR9) 2020; 30
Lignitto, Arcella, Sepe, Rinaldi, Delle Donne, Gallo (CR27) 2013; 4
Song, Wang, Chi, Wei, Xu, Yu (CR28) 2019; 29
Chen, Song (CR6) 2019; 18
Kastrinos, Samadder, Burt (CR4) 2020; 158
Hinshaw, Shevde (CR5) 2019; 79
CR39
Ma, Meng, Chen, Guan (CR32) 2019; 88
Fang, Lv, Lv, Li, Wang, Han (CR17) 2018; 9
CR13
Ignatiadis, Sledge, Jeffrey (CR36) 2021; 18
Ye, Ling, Zheng, Xu (CR37) 2019; 18
Herrera, Llorens, Rodriguez, Herrera, Ramos, Gil (CR20) 2018; 17
Hu, Wang, Lan, Zeng, Liang, Yan (CR16) 2019; 18
Biffi, Tuveson (CR10) 2021; 101
Ponting, Oliver, Reik (CR22) 2009; 136
Hong, Meng, Guan (CR33) 2016; 13
Zhao, Wei, Li, Udan, Yang, Kim (CR34) 2007; 21
DeBerardinis (CR8) 2020; 382
Bregni, Sciallero, Sobrero (CR3) 2019; 5
Harvey, Zhang, Thomas (CR35) 2013; 13
Karreth, Pandolfi (CR21) 2013; 3
Jiang, Wang, Lin, Ma, Cui, Wang (CR31) 2020; 22
Zeng, Li, Pan, Lan, Song, Sun (CR38) 2018; 9
Vitale, Manic, Coussens, Kroemer, Galluzzi (CR7) 2019; 30
Wang, Yang, Chen, Liu, Guo, Zhu (CR23) 2019; 18
Nandi, Tahiliani, Kumar, Chandu (CR25) 2006; 31
Sun, Yang, Zhou, Wang, Song, Li (CR14) 2018; 17
Richards, Zeleniak, Fishel, Wu, Littlepage, Hill (CR19) 2017; 36
Kobayashi, Enomoto, Woods, Burt, Takahashi, Worthley (CR11) 2019; 16
Hu, Huang, Yan, Zhou, Wang, Wu (CR30) 2019; 508
Raposo, Stoorvogel (CR12) 2013; 200
Siegel, Miller, Jemal (CR1) 2019; 69
Zheng, Shabek (CR26) 2017; 86
Qin, Guo, Wang, Zhu, Yan, Wang (CR15) 2019; 20
Wang, Huang, Qian, Wang, Zheng, Jiang (CR29) 2020; 526
Catalano, O’Driscoll (CR18) 2020; 9
Chen, Chen, Yu, Nie, Yan, Ma (CR24) 2018; 24
Low, Wong, Wu, Kong, Png, Cho (CR40) 2021; 12
T Fang (5240_CR17) 2018; 9
JL Hu (5240_CR16) 2019; 18
M Herrera (5240_CR20) 2018; 17
M Catalano (5240_CR18) 2020; 9
E Dekker (5240_CR2) 2019; 394
Z Zeng (5240_CR38) 2018; 9
G Bregni (5240_CR3) 2019; 5
FA Karreth (5240_CR21) 2013; 3
F Kastrinos (5240_CR4) 2020; 158
Q Ye (5240_CR37) 2019; 18
5240_CR39
5240_CR13
L Lignitto (5240_CR27) 2013; 4
I Vitale (5240_CR7) 2019; 30
DC Hinshaw (5240_CR5) 2019; 79
J Song (5240_CR28) 2019; 29
B Jiang (5240_CR31) 2020; 22
RJ DeBerardinis (5240_CR8) 2020; 382
N Zheng (5240_CR26) 2017; 86
X Chen (5240_CR24) 2018; 24
NM Anderson (5240_CR9) 2020; 30
S Ma (5240_CR32) 2019; 88
H Kobayashi (5240_CR11) 2019; 16
Y Wang (5240_CR23) 2019; 18
RL Siegel (5240_CR1) 2019; 69
R Wang (5240_CR29) 2020; 526
X Qin (5240_CR15) 2019; 20
D Nandi (5240_CR25) 2006; 31
KE Richards (5240_CR19) 2017; 36
HB Low (5240_CR40) 2021; 12
X Chen (5240_CR6) 2019; 18
B Zhao (5240_CR34) 2007; 21
Z Sun (5240_CR14) 2018; 17
G Biffi (5240_CR10) 2021; 101
G Raposo (5240_CR12) 2013; 200
AW Hong (5240_CR33) 2016; 13
M Ignatiadis (5240_CR36) 2021; 18
CP Ponting (5240_CR22) 2009; 136
Z Hu (5240_CR30) 2019; 508
KF Harvey (5240_CR35) 2013; 13
References_xml – volume: 101
  start-page: 147
  year: 2021
  end-page: 76
  ident: CR10
  article-title: Diversity and biology of cancer-associated fibroblasts
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00048.2019
– volume: 12
  year: 2021
  ident: CR40
  article-title: DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-22638-7
– ident: CR39
– volume: 13
  start-page: 324
  year: 2016
  end-page: 37
  ident: CR33
  article-title: The Hippo pathway in intestinal regeneration and disease
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2016.59
– volume: 158
  start-page: 389
  year: 2020
  end-page: 403
  ident: CR4
  article-title: Use of family history and genetic testing to determine risk of colorectal cancer
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.11.029
– volume: 4
  year: 2013
  ident: CR27
  article-title: Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth
  publication-title: Nat Commun
  doi: 10.1038/ncomms2791
– volume: 18
  year: 2019
  ident: CR37
  article-title: Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
  publication-title: Mol cancer
  doi: 10.1186/s12943-019-1043-x
– volume: 79
  start-page: 4557
  year: 2019
  end-page: 66
  ident: CR5
  article-title: The tumor microenvironment innately modulates cancer progression
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-3962
– volume: 9
  start-page: 1703244
  year: 2020
  ident: CR18
  article-title: Inhibiting extracellular vesicles formation and release: a review of EV inhibitors
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2019.1703244
– volume: 136
  start-page: 629
  year: 2009
  end-page: 41
  ident: CR22
  article-title: Evolution and functions of long noncoding RNAs
  publication-title: Cell
  doi: 10.1016/j.cell.2009.02.006
– volume: 22
  start-page: 5069
  year: 2020
  end-page: 82
  ident: CR31
  article-title: Antisense long non‑coding RNA WEE2‑AS1 regulates human vascular endothelial cell viability via cell cycle G2/M transition in arteriosclerosis obliterans
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2020.11625
– volume: 9
  year: 2018
  ident: CR38
  article-title: Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-07810-w
– volume: 394
  start-page: 1467
  year: 2019
  end-page: 80
  ident: CR2
  article-title: Colorectal cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)32319-0
– volume: 24
  start-page: 2002
  year: 2018
  end-page: 14
  ident: CR24
  article-title: Long noncoding RNA LINC01234 functions as a competing endogenous RNA to regulate CBFB expression by sponging miR-204-5p in gastric cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-17-2376
– volume: 17
  year: 2018
  ident: CR14
  article-title: Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0831-z
– volume: 526
  start-page: 1005
  year: 2020
  end-page: 12
  ident: CR29
  article-title: LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2020.01.170
– volume: 5
  start-page: 605
  year: 2019
  end-page: 6
  ident: CR3
  article-title: HER2 amplification and anti-EGFR sensitivity in advanced colorectal cancer
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2018.7229
– volume: 18
  year: 2019
  ident: CR23
  article-title: A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis
  publication-title: Mol Cancer
  doi: 10.1186/s12943-019-0957-7
– volume: 36
  start-page: 1770
  year: 2017
  end-page: 8
  ident: CR19
  article-title: Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
  publication-title: Oncogene
  doi: 10.1038/onc.2016.353
– volume: 20
  year: 2019
  ident: CR15
  article-title: Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5
  publication-title: Genome Biol
  doi: 10.1186/s13059-018-1604-0
– volume: 13
  start-page: 246
  year: 2013
  end-page: 57
  ident: CR35
  article-title: The Hippo pathway and human cancer
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3458
– volume: 86
  start-page: 129
  year: 2017
  end-page: 57
  ident: CR26
  article-title: Ubiquitin ligases: structure, function, and regulation
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev-biochem-060815-014922
– volume: 69
  start-page: 7
  year: 2019
  end-page: 34
  ident: CR1
  article-title: Cancer statistics, 2019
  publication-title: CA: Cancer J. Clin
– volume: 21
  start-page: 2747
  year: 2007
  end-page: 61
  ident: CR34
  article-title: Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
  publication-title: Genes Dev
  doi: 10.1101/gad.1602907
– ident: CR13
– volume: 18
  start-page: 297
  year: 2021
  end-page: 312
  ident: CR36
  article-title: Liquid biopsy enters the clinic—implementation issues and future challenges
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-020-00457-x
– volume: 18
  start-page: 99
  year: 2019
  end-page: 115
  ident: CR6
  article-title: Turning foes to friends: targeting cancer-associated fibroblasts
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-018-0004-1
– volume: 16
  start-page: 282
  year: 2019
  end-page: 95
  ident: CR11
  article-title: Cancer-associated fibroblasts in gastrointestinal cancer
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-019-0115-0
– volume: 508
  start-page: 79
  year: 2019
  end-page: 86
  ident: CR30
  article-title: Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2018.11.091
– volume: 200
  start-page: 373
  year: 2013
  end-page: 83
  ident: CR12
  article-title: Extracellular vesicles: exosomes, microvesicles, and friends
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201211138
– volume: 3
  start-page: 1113
  year: 2013
  end-page: 21
  ident: CR21
  article-title: ceRNA cross-talk in cancer: when ce-bling rivalries go awry
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-13-0202
– volume: 9
  year: 2018
  ident: CR17
  article-title: Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-02583-0
– volume: 29
  start-page: 3664
  year: 2019
  end-page: 3677
  ident: CR28
  article-title: Kindlin-2 inhibits the hippo signaling pathway by promoting degradation of MOB1
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2019.11.035
– volume: 30
  start-page: R921
  year: 2020
  end-page: r925
  ident: CR9
  article-title: The tumor microenvironment
  publication-title: Curr Biol: CB
  doi: 10.1016/j.cub.2020.06.081
– volume: 18
  year: 2019
  ident: CR16
  article-title: CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer
  publication-title: Mol Cancer
  doi: 10.1186/s12943-019-1019-x
– volume: 88
  start-page: 577
  year: 2019
  end-page: 604
  ident: CR32
  article-title: The Hippo pathway: biology and pathophysiology
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev-biochem-013118-111829
– volume: 382
  start-page: 869
  year: 2020
  end-page: 71
  ident: CR8
  article-title: Tumor microenvironment, metabolism, and immunotherapy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcibr1914890
– volume: 30
  start-page: 36
  year: 2019
  end-page: 50
  ident: CR7
  article-title: Macrophages and metabolism in the tumor microenvironment
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.06.001
– volume: 17
  year: 2018
  ident: CR20
  article-title: Differential distribution and enrichment of non-coding RNAs in exosomes from normal and Cancer-associated fibroblasts in colorectal cancer
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0863-4
– volume: 31
  start-page: 137
  year: 2006
  end-page: 55
  ident: CR25
  article-title: The ubiquitin-proteasome system
  publication-title: J Biosci
  doi: 10.1007/BF02705243
– volume: 508
  start-page: 79
  year: 2019
  ident: 5240_CR30
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2018.11.091
– volume: 31
  start-page: 137
  year: 2006
  ident: 5240_CR25
  publication-title: J Biosci
  doi: 10.1007/BF02705243
– ident: 5240_CR39
  doi: 10.1002/ctm2.211
– volume: 86
  start-page: 129
  year: 2017
  ident: 5240_CR26
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev-biochem-060815-014922
– volume: 30
  start-page: 36
  year: 2019
  ident: 5240_CR7
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2019.06.001
– volume: 9
  start-page: 1703244
  year: 2020
  ident: 5240_CR18
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2019.1703244
– volume: 9
  year: 2018
  ident: 5240_CR17
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-02583-0
– volume: 22
  start-page: 5069
  year: 2020
  ident: 5240_CR31
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2020.11625
– volume: 21
  start-page: 2747
  year: 2007
  ident: 5240_CR34
  publication-title: Genes Dev
  doi: 10.1101/gad.1602907
– ident: 5240_CR13
  doi: 10.1126/science.aau6977
– volume: 9
  year: 2018
  ident: 5240_CR38
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-07810-w
– volume: 30
  start-page: R921
  year: 2020
  ident: 5240_CR9
  publication-title: Curr Biol: CB
  doi: 10.1016/j.cub.2020.06.081
– volume: 18
  year: 2019
  ident: 5240_CR37
  publication-title: Mol cancer
  doi: 10.1186/s12943-019-1043-x
– volume: 13
  start-page: 324
  year: 2016
  ident: 5240_CR33
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2016.59
– volume: 394
  start-page: 1467
  year: 2019
  ident: 5240_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)32319-0
– volume: 18
  start-page: 297
  year: 2021
  ident: 5240_CR36
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/s41571-020-00457-x
– volume: 5
  start-page: 605
  year: 2019
  ident: 5240_CR3
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2018.7229
– volume: 382
  start-page: 869
  year: 2020
  ident: 5240_CR8
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcibr1914890
– volume: 18
  year: 2019
  ident: 5240_CR16
  publication-title: Mol Cancer
  doi: 10.1186/s12943-019-1019-x
– volume: 18
  start-page: 99
  year: 2019
  ident: 5240_CR6
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/s41573-018-0004-1
– volume: 101
  start-page: 147
  year: 2021
  ident: 5240_CR10
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00048.2019
– volume: 3
  start-page: 1113
  year: 2013
  ident: 5240_CR21
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-13-0202
– volume: 200
  start-page: 373
  year: 2013
  ident: 5240_CR12
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201211138
– volume: 29
  start-page: 3664
  year: 2019
  ident: 5240_CR28
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2019.11.035
– volume: 4
  year: 2013
  ident: 5240_CR27
  publication-title: Nat Commun
  doi: 10.1038/ncomms2791
– volume: 69
  start-page: 7
  year: 2019
  ident: 5240_CR1
  publication-title: CA: Cancer J. Clin
– volume: 526
  start-page: 1005
  year: 2020
  ident: 5240_CR29
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2020.01.170
– volume: 158
  start-page: 389
  year: 2020
  ident: 5240_CR4
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2019.11.029
– volume: 17
  year: 2018
  ident: 5240_CR14
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0831-z
– volume: 136
  start-page: 629
  year: 2009
  ident: 5240_CR22
  publication-title: Cell
  doi: 10.1016/j.cell.2009.02.006
– volume: 18
  year: 2019
  ident: 5240_CR23
  publication-title: Mol Cancer
  doi: 10.1186/s12943-019-0957-7
– volume: 36
  start-page: 1770
  year: 2017
  ident: 5240_CR19
  publication-title: Oncogene
  doi: 10.1038/onc.2016.353
– volume: 79
  start-page: 4557
  year: 2019
  ident: 5240_CR5
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-18-3962
– volume: 17
  year: 2018
  ident: 5240_CR20
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0863-4
– volume: 20
  year: 2019
  ident: 5240_CR15
  publication-title: Genome Biol
  doi: 10.1186/s13059-018-1604-0
– volume: 13
  start-page: 246
  year: 2013
  ident: 5240_CR35
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3458
– volume: 24
  start-page: 2002
  year: 2018
  ident: 5240_CR24
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-17-2376
– volume: 88
  start-page: 577
  year: 2019
  ident: 5240_CR32
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev-biochem-013118-111829
– volume: 12
  year: 2021
  ident: 5240_CR40
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-22638-7
– volume: 16
  start-page: 282
  year: 2019
  ident: 5240_CR11
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/s41575-019-0115-0
SSID ssj0000330256
Score 2.5000815
Snippet Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor progression....
Abstract Cancer-associated fibroblasts (CAFs) are the most abundant stromal components in the tumor microenvironment (TME) and closely involved in tumor...
SourceID doaj
unpaywall
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 796
SubjectTerms 13/1
14/19
14/32
631/67/1504/1885
631/67/327
82
82/51
82/58
Adaptor Proteins, Signal Transducing - metabolism
Animals
Antibodies
Biochemistry
Biomedical and Life Sciences
Carcinogenesis
Cell Biology
Cell Culture
Cell Cycle Proteins - genetics
Cell proliferation
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - pathology
Degradation
DNA, Antisense
Extracellular vesicles
Fibroblasts
Hippo Signaling Pathway
Humans
Immunology
Life Sciences
Medical prognosis
Mice
Mice, Nude
Molecular modelling
Proteasome Endopeptidase Complex - metabolism
Proteasomes
Protein-Tyrosine Kinases - genetics
RNA, Long Noncoding - genetics
Therapeutic targets
Tumor Microenvironment
Tumorigenesis
Ubiquitin
Ubiquitin-protein ligase
Ubiquitin-Protein Ligases - genetics
Ubiquitin-Protein Ligases - metabolism
Ubiquitins
Yes-associated protein
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJQQcEG8CBRmJG40aO87ruK12tUIqHKCit8hxxjTSkqy6u233F_RvM2Nnw65AhQPHxLbkeL7xzMTjbxh7r5TMBFDVgAq1SUFehNoWSVhHaZUkWqMJpv-QJ5_S6an6eJacbZX6opwwTw_sF-6QOKKMjWuAIlFxhB-eKRdEqEJbm7t75FFebAVTbg_GMB2NeX9LJorzw4USiu7rYOwVJZLS6HYskSPs_5OX-Xuy5HBi-oDdW7Vzvb7Ss9mWUZo8Yg97b5KP_Fc8ZnegfcLu-vqS66fs5ng0CWvE2CXUHK67RfcDe38bj2U4-iK41cZzdMOCE3k1bX7YbggIF9xlbnnWDn7ZaHqmxL32O6-JYMLXYuKd5Sefj8SILzvetOdN1Sw5-pR82sznHad6x1d6_YydTsZfj6dhX3khNOjBLUOVWSImM8KgxyBNDonOtDAVOm86hhxUXcVCJSDSFGRaRRCn1kbayrqSuJND_JzttV0LLxmvFNRCgMkKFJy0Kq9sEiFsMrScAqwJmNhIoTQ9LTlVx5iV7ng8zksvuRIlVzrJlVnAPgxj5p6U49beRyTcoScRarsXCLOyh1n5N5gFbH8DjbLX8kWJMEf3EWNMbH43NKN-0qGLbqFbuT4pkS5KEbAXHknDTGLivokljs52MLYz1d2Wtjl3HOBE6iNEEbCDDRp_Teu2pTgYEPsPK_fqf6zca3ZfOq0rQlHss73lxQreoCO3rN46nf0JgdhByQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZGJwQ8IG6DwkBG4o1Fix3n9oBQO7WqkFYQMLG3yPFli1SS0stGfwF_m3Ocy6hAFY-J7cjx-Y7PsX38HULeCMFjZjBrQA7aJEySetKmoaf9KA9DKcEE4z7k6TSanIkP5-H5Hpm2d2EwrLKdE91ErSuFe-TH8Ekw1eDPx-_nPzzMGoWnq20KDdmkVtDvHMXYLbLPkRmrR_aHo-mnz92uiw_LdzDyze0ZP0iOl4IJvMcDazI_5Bhet2WhHJH_v7zPv4Mou5PUe-TOupzLzbWczf4wVuMH5H7jZdJBDYuHZM-Uj8jtOu_k5jH5dTIYexqwd2U0NT-rZfUdan8bjbg3-MKolarm7jZLiqTWOClCuUKALKiL6KrZPOhVIfEZA_rKC6qReKLO0UQrS08_DtmAripalJdFXqwo-Jp0UsznFcU8yNdy84ScjUdfTyZek5HBU-DZrTwRWyQsU0yBJ8FVYkIZS6ZycOpkYBIjdB4wERoWRYZHuW-CyFpfWq5zDjO8CQ5Ir6xK84zQXBjNmFFxqmF1bkWS29AHOMVgUZmxqk9YK4VMNXTlmDVjlrlj8yDJasllILnMSS6L--Rt12Zek3XsrD1E4XY1kWjbvagWF1mjtxlSlCkbaGPSUAQ-6F0s3BpWpNLaBD5y2EIja7R_md1gtU9ed8Wgt3gYI0tTrV2dCMkYOeuTpzWSup4EyIkTcGgdb2Fsq6vbJWVx6bjBkeyHsbRPjlo03nRr11AcdYj9j5F7vvunX5C73OlT6rH0kPRWi7V5Ca7bKn_V6ONvuzxACA
  priority: 102
  providerName: ProQuest
– databaseName: HAS SpringerNature Open Access 2022
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELbKVohyQLy7UJCRuLERseO8jmm1q9VKhUOp6C2ynTGNtCSrbrZlfwF_m7GTDURFFRwTP2R5vvHM-PENIe-F4DEDmzVAoTYJSFJPmjT0Cj9SYSglmmC7D3n6KZqfi8VFeLFHJru3MIPze0fdvRZM2Ic2GDT5Ibf33-6R_QSBmYzIfpYtzhb9noqPwTma8O5tDDb_eLvxwP44mv6_-Za3r0j256QPyYNNtZLbG7lc_mGKZo_Jo86HpFkr9CdkD6qn5H6bVXL7jPw8yWZegci6hoLCj3pdf8faX6dT7mVnjBqpW2ZuWFNLWW2XPCzXVvxX1N3Xark66HUp7be9rld9o4WllWgzMNHa0NPPxyyjTU3L6rJUZUPRk6TzcrWqqc1yfCO3z8n5bPrlZO51-RY8jX5b44nYWDoyzTT6CVwnEMpYMq3QZZMBJCAKFTARAosi4JHyIYiM8aXhheK4fkPwgoyquoJDQpWAgjHQcVpg7G1EokzoI1hitJcMjB4TtpNCrjsycpsTY5m7Q_EgyVvJ5Si53Ekuj8fkQ99m1VJx3Fn72Aq3r2lptN0PRFfeaWVuCci0CQqANBSBj1oVCxehilQak2AnRzto5J1ur3MENzqNGFli8bu-GLXSHrXICuqNqxNZqkXOxuRli6R-JIFlvAk4to4HGBsMdVhSlZeO-dtS-TCWjslkh8bfw7prKiY9Yv9h5l79X--vyQF3-pV6LD0io-ZqA2_QUWvU204_fwH39DQb
  priority: 102
  providerName: Springer Nature
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdGJ8R44PujMJCReGMpceJ8PXZTqwppAwmqjafIds5bRJdUbbpR_gH-bc7OBxSmiT22PlfO5c73u_r8O0Lecu5FDEzXAInexCFOHKGTwMncUAaBEBiCzf-Qh0fhZMo_nAQnWyRs78LYon1LaWm36bY67P2SM26u22Dq5AaeqYIbzDN9i2yHAWLwHtmeHn0afjWd5FyOSVEcJ80NGdePr5i8EYUsWf9VCPPfQsnutPQuubMq5mJ9KWazPwLS-D45bh-lrkP5NlhVcqB-_MXyePNnfUDuNRiVDmvJh2QLikfkdt21cv2Y_DwYjp0MLfcCMgrfy2V5jtLHo5HnDD8zqoWqmb9hSQ0lttlScVwZ81pQWw9Wc4HQi1yYz6YcsDilmaGtqDs80VLTw4_7bEirkubFWS7ziiJSpZN8Pi-p6aJ8KdZPyHQ8-nIwcZp-Do5CXFg5PNKG7kwxhTjEUzEEIhJMSYSEwocYeCZ9xgNgYQheKF3wQ61dob1MehgfwH9KekVZwHNCJYeMMVBRkmFur3ksdeCiMUYYjxlo1Sesfb-pasjOTc-NWWoP3f04rZWcopJTq-Q06pN33Zx5TfVxrfS-MZtO0tB02y_KxWnavMrUEJwp7WcAScB9F7024jYD5onQOsYf2W2NLm32jmWKzoOgFDNXHH7TDaPXm6McUUC5sjKhoXL0WJ88q220W4lvGHV8D2dHG9a7sdTNkSI_s8zihiqIsaRP9lo7_72s61Sx1_nCf2juxc3EX5Idz7pC4rBkl_SqxQpeIRCs5OvG638Bo5RWtg
  priority: 102
  providerName: Unpaywall
Title CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway
URI https://link.springer.com/article/10.1038/s41419-022-05240-7
https://www.ncbi.nlm.nih.gov/pubmed/36123327
https://www.proquest.com/docview/2715621497
https://www.proquest.com/docview/2716087721
https://pubmed.ncbi.nlm.nih.gov/PMC9485119
https://www.nature.com/articles/s41419-022-05240-7.pdf
https://doaj.org/article/0557cf3dee95430ead746010449aff87
UnpaywallVersion publishedVersion
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: KQ8
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: DIK
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: M~E
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: RPM
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVAQT
  databaseName: Springer Nature - nature.com Journals - Fully Open Access
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: NAO
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.nature.com/siteindex/index.html
  providerName: Nature Publishing
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 20221231
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: 7X7
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 2041-4889
  dateEnd: 20221231
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: BENPR
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: M48
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVAVX
  databaseName: HAS SpringerNature Open Access 2022
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: AAJSJ
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.springernature.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: Springer Nature OA Free Journals
  customDbUrl:
  eissn: 2041-4889
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000330256
  issn: 2041-4889
  databaseCode: C6C
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.springeropen.com/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZ2EQIeEHcKozISbywsdpzbA0Jp1aqq1DIxKspT5CT2FqkkpZdt_QX8bc5x0kDFNMFTlNiJLJ_v2OfE9vcR8lYI7jOFqgEJeJNQQWhJHbpWZnuJ60oJUzD-hxyNvcFEDKfudI9s5Y7qDlzemNqhntRkMXt__WPzERz-Q3VkPDhZCibwKA6kVbbLcYfcPjmEa4hSDqM63DcjMyTv3Ai6cltA6hQEYX2O5ubP7MxVhtL_pjj07-2UzZrqfXJ3Xczl5krOZn9MW_2H5EEdb9KoAsgjsqeKx-ROpUC5eUJ-dqO-lQEKL1VG1XW5LL9D7a-9HreiM0a1TCsWb7WkSG-NwyOUpwiVBTV7uypeD3qZS7zHrX3FOc2QgqJSa6KlpqNPHRbRVUnz4iJP8hWFqJMO8vm8pKiIfCU3T8mk3_vSHVi1NoOVQoy3soSvkbosZSnEFDwNlCt9ydIEwjvpqECJLHGYcBXzPMW9xFaOp7UtNc8SDmO9cp6Rg6Is1AtCE6EyxlTqhxnk6VoEiXZtAJYPcytTOm0RtrVCnNbE5aifMYvNAroTxJXlYrBcbCwX-y3yrnlnXtF23Fq7g8ZtaiLltnlQLs7j2oNjJCtLtZMpFbrCscEDfWGyWRFKrQP4yNEWGvEWxjE4AgSYkIVC8ZumGDwYl2Vkocq1qeMhLSNnLfK8QlLTEgfZcRwOb_s7GNtp6m5JkV8YlnCk_WEsbJHjLRp_N-u2rjhuEPsPPffyv_r5FbnHjXuFFguPyMFqsVavIaZbJW2y70_9NjmMouHZEK6d3vj0Mzztet22-U_SNq4MJZPxafTtF2coSdA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJzR4QNwpDDASPLFo8SW3hwm1o1XH1oJg0_YWnMTeKpWk9LLSX8C_4rdxTm6jAlW87LG1Yzk5V9vH30fIaym5xzSyBkRgTVL7gaVM4FiJ7UaOoxSEYNyH7A_c3on8cOacbZBf1V0YLKusfGLuqJMsxj3yXRgSQjXk89678XcLWaPwdLWi0FAltUKyl0OMlRc7DvVyAUu46d7Be5D3G867neP9nlWyDFgxZCszS3oGQbhiFkN05LGvHeUpFkeQqCihfS2TSDDpaOa6mruRrYVrjK0MTyIOXksLGPcG2ZQCptYgm-3O4NPnepfHFgKTivK2ji383alkEu8NwRrQdjiW861ExJw44F_Z7t9Fm_XJ7W2yNU_HarlQo9EfwbF7l9wps1raKtTwHtnQ6X1ys-C5XD4gP_dbXSsBXb_UCdU_smn2DXqfdjrcan1h1Ki4wArXU4og2uiEoT1GhZzQvIKsQA-hl0OFv7GAMD2nCQJdFJxQNDO0_7HNWnSW0WF6MYyGMwq5Le0Nx-OMIu_yQi0fkpNrkc0j0kizVD8hNJI6YUzHXpB4khvpR8axQX09iOBMm7hJWCWFMC7h0ZGlYxTmx_TCDwvJhSC5MJdc6DXJ2_qZcQEOsrZ3G4Vb90Rg7_yPbHIeln4iREi02IhE68CRwgY792S-ZpaBMsaHQbYr1QhLbzMNr2yjSV7VzeAn8PBHpTqb531cBH_krEkeF5pUz0QgBo_g8LS3omMrU11tSYcXORY5ggsxFjTJTqWNV9Na9yl2ao39jy_3dP1LvyRbveP-UXh0MDh8Rm7x3LYCiwXbpDGbzPVzSBtn0YvSNin5et3u4DcuGX4O
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGELcHxJ3CACPBE4saXxInDwh1W6uOsYEE0_oWnMTeKpWk9LLSX8B_4tdxTm6jAlW87LG1Yzk537nYPv4OIa-k5IoZrBoQgzZJE4SOtqHnpK4fe57W4IJxH_LwyO8fy_cDb7BBftV3YTCtsraJhaFO8wT3yNswJLhqiOdV21ZpEZ_2eu_G3x2sIIUnrXU5jRIiB2a5gOXb9O3-Hsj6Nee97pfdvlNVGHASiFRmjlQWCbgSloBn5ElgPK00S2IIUrQwgZFpLJj0DPN9w_3YNcK31tWWpzEHi2UEjHuFXFVChJhOqAaq2d9xhcBworqn44qgPZVM4o0hWP25HsdEvhVfWJQM-Fec-3e6ZnNme4vcmGdjvVzo0egPt9i7Q25X8SztlAC8SzZMdo9cKytcLu-Tn7udnpMCys9NSs2PfJp_g94n3S53Op8ZtTopWcLNlCJ9NppfaE8QihNa5I6VvCH0fKjxN6YOZqc0RYqLshoUzS09_LjDOnSW02F2NoyHMwpRLe0Px-OcYsXlhV4-IMeXIpmHZDPLM_OY0FialDGTqDBVklsZxNZzAbgKfDczNmkRVkshSipidKzPMYqKA3oRRKXkIpBcVEguUi3ypnlmXNKCrO29g8JteiKld_FHPjmNKgsRIRlaYkVqTOhJ4YKGK1mslmWorQ1gkK0aGlFlZ6bRhVa0yMumGSwEHvvozOTzoo-PtI-ctcijEknNTASy7wgOT6sVjK1MdbUlG54VLORIK8RY2CLbNRovprXuU2w3iP2PL_dk_Uu_INfBCEQf9o8OnpKbvFCt0GHhFtmcTebmGcSLs_h5oZiUfL1sS_AbtUF7qA
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdGJ8R44PujMJCReGMpceJ8PXZTqwppAwmqjafIds5bRJdUbbpR_gH-bc7OBxSmiT22PlfO5c73u_r8O0Lecu5FDEzXAInexCFOHKGTwMncUAaBEBiCzf-Qh0fhZMo_nAQnWyRs78LYon1LaWm36bY67P2SM26u22Dq5AaeqYIbzDN9i2yHAWLwHtmeHn0afjWd5FyOSVEcJ80NGdePr5i8EYUsWf9VCPPfQsnutPQuubMq5mJ9KWazPwLS-D45bh-lrkP5NlhVcqB-_MXyePNnfUDuNRiVDmvJh2QLikfkdt21cv2Y_DwYjp0MLfcCMgrfy2V5jtLHo5HnDD8zqoWqmb9hSQ0lttlScVwZ81pQWw9Wc4HQi1yYz6YcsDilmaGtqDs80VLTw4_7bEirkubFWS7ziiJSpZN8Pi-p6aJ8KdZPyHQ8-nIwcZp-Do5CXFg5PNKG7kwxhTjEUzEEIhJMSYSEwocYeCZ9xgNgYQheKF3wQ61dob1MehgfwH9KekVZwHNCJYeMMVBRkmFur3ksdeCiMUYYjxlo1Sesfb-pasjOTc-NWWoP3f04rZWcopJTq-Q06pN33Zx5TfVxrfS-MZtO0tB02y_KxWnavMrUEJwp7WcAScB9F7024jYD5onQOsYf2W2NLm32jmWKzoOgFDNXHH7TDaPXm6McUUC5sjKhoXL0WJ88q220W4lvGHV8D2dHG9a7sdTNkSI_s8zihiqIsaRP9lo7_72s61Sx1_nCf2juxc3EX5Idz7pC4rBkl_SqxQpeIRCs5OvG638Bo5RWtg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CAF-derived+exosomal+WEE2-AS1+facilitates+colorectal+cancer+progression+via+promoting+degradation+of+MOB1A+to+inhibit+the+Hippo+pathway&rft.jtitle=Cell+death+%26+disease&rft.au=Yang%2C+Peng&rft.au=Zhang%2C+Dongsheng&rft.au=Wang%2C+Tuo&rft.au=Ji%2C+Jiangzhou&rft.date=2022-09-19&rft.issn=2041-4889&rft.eissn=2041-4889&rft.volume=13&rft.issue=9&rft_id=info:doi/10.1038%2Fs41419-022-05240-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41419_022_05240_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon